MidAmerica Cardiovascular Institute — Omaha, Nebraska

MidAmerica Cardiovascular Institute is a clinical research site located in Omaha, Nebraska, United States 68131.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

MidAmerica Cardiovascular Institute has participated in 1 clinical trials.

Therapeutic areas: Stroke, Atrial Fibrillation.

Sponsors: Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidAmerica Cardiovascular Institute?

MidAmerica Cardiovascular Institute has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidAmerica Cardiovascular Institute conducted?

MidAmerica Cardiovascular Institute has 1 clinical trials on record. Their work covers Stroke, Atrial Fibrillation.

Is MidAmerica Cardiovascular Institute accredited by Crixeo Health?

MidAmerica Cardiovascular Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidAmerica Cardiovascular Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.